Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Esposito, Susanna ^a   Garziano, Micaela ^b   Rainone, Veronica ^b   Trabattoni, Daria ^b   Biasin, Mara ^b   Senatore, Laura ^a   Marchisio, Paola ^a   Rossi, Marta ^a   Principi, Nicola ^a   Clerici, Mario ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Children; Community acquired pneumonia; Immunomodulatory activity; Immunostimulants; Pidotimod; Respiratory tract infection

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CLARITHROMYCIN; INTERLEUKIN 12; MESSENGER RNA; PIDOTIMOD; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; ANTIINFECTIVE AGENT; BACTERIAL POLYSACCHARIDE; IMMUNOLOGICAL ADJUVANT; PEPTIDE; PYROGLUTAMIC ACID; THIAZOLIDINE DERIVATIVE; TUMOR NECROSIS FACTOR;

ANTIBIOTIC THERAPY; ARTICLE; BLOOD SAMPLING; CELL COUNT; CHILD; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG RESPONSE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; PRESCHOOL CHILD; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ADOLESCENT; ANALOGS AND DERIVATIVES; CHEMISTRY; COMMUNITY-ACQUIRED INFECTIONS; HOSPITALIZATION; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; METABOLISM; PNEUMONIA; RESPIRATORY TRACT INFECTIONS;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DENDRITIC CELLS; FEMALE; HOSPITALIZATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-12; MALE; PEPTIDES; PNEUMONIA; POLYSACCHARIDES, BACTERIAL; PYRROLIDONECARBOXYLIC ACID; RESPIRATORY TRACT INFECTIONS; RNA, MESSENGER; THIAZOLIDINES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84940666889     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0649-z     Document Type: Article

References (33)

1. Principi N, Esposito S, Cavagna R, Bosis S, Droghetti R, Faelli N, et al. Recurrent respiratory tract infections in pediatric age: a population-based survey of the therapeutic role of macrolides. J Chemother. 2003;15:53-9.
2. Patria F, Longhi B, Tagliabue C, Tenconi R, Ballista P, Ricciardi G, et al. Clinical profile of recurrent community-acquired pneumonia in children. BMC Pulm Med. 2013;13:60.
3. Ewing P, Otczyk DC, Occhipinti S, Kyd JM, Gleeson M, Cripps AW. Developmental profiles of mucosal immunity in pre-school children. Clin Dev Immunol. 2010;2010:196785.
4. Marodi L. Innate cellular immune responses in newborns. Clin Immunol. 2006;118:137-44.
5. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007;7:379-90.
6. Vigano A, Esposito S, Arienti D, Zagliani A, Massironi E, Principi N, et al. Differential development of type 1 and type 2 cytokines and beta-chemokines in the ontogeny of healthy newborns. Biol Neonate. 1999;75:1-8.
7. Brodin P, Jojic V, Gao T, Bhattacharya S, Angel CJ, Furman D, et al. Variation in the human immune system is largely driven by non-heritable influences. Cell. 2015;160:37-47.
8. Notarangelo LD. Immunodeficiency and immune dysregulation associated with proximal defects of T cell receptor signaling. Curr Opin Immunol. 2014;31:97-101.
9. Tomlinson G, Chimalapati S, Pollard T, Lapp T, Cohen J, Camberlein E, et al. TLR-mediated inflammatory responses to Streptococcus pneumoniae are highly dependent on surface expression of bacterial lipoproteins. J Immunol. 2014;193:3736-45.
10. Labuda LA, de Jong SE, Meurs L, Amoah AS, Mbow M, Ateba-Ngoa U, et al. Differences in innate cytokine responses between European and African children. PLoS One. 2014;9:e95241.
11. Evans SE, Xu Y, Tuvim MJ, Dickey BF. Inducible innate resistance of lung epithelium to infection. Annu Rev Physiol. 2010;72:413-35.
12. Vareille M, Kieninger E, Edwards MR, Regamey N. The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev. 2011;24:210-29.
13. Heier I, Malmstrom K, Sajantila A, Lohi J, Makela M, Jahnsen FL. Characterisation of bronchus-associated lymphoid tissue and antigen-presenting cells in central airway mucosa of children. Thorax. 2011;66:151-6.
14. Heier I, Malmstrom K, Pelkonen AS, Malmberg LP, Kajosaari M, Turpeinen M, et al. Bronchial response pattern of antigen presenting cells and regulatory T cells in children less than 2 years of age. Thorax. 2008;63:703-9.
15. Esposito S, Musio A. Immunostimulants and prevention of recurrent respiratory tract infections. J Biol Regul Homeost Agents. 2013;27:627-36.
16. Feleszko W, Ruszczyński M, Zalewski BM. Non-specific immune stimulation in respiratory tract infections. Separating the wheat from the chaff. Paediatr Respir Rev. 2014;15:200-6.
17. Esposito S, Castellazzi L, Garbarino F. Can probiotic administration during pregnancy and the first year of life effectively reduce the risk of infections and allergic diseases in childhood? J Biol Regul Homeost Agents. 2014;28:565-73.
18. Auteri A, Pasqui AL, Bruni F, Saletti M, Di Renzo M, Bova G. Effect of pidotimod, a new immunostimulating agent, on some aspects of immune response. In vitro study. Pharmacol Res. 1992;26:196-7.
19. Migliorati G, D'Adamio L, Coppi G, Nicoletti I, Riccardi C. Pidotimod stimulates natural killer cell activity and inhibits thymocyte cell death. Immunopharmacol Immunotoxicol. 1992;14:737-48.
20. Carta S, Silvestri M, Rossi GA. Modulation of airway epithelial cell functions by pidotimod: NF-kB cytoplasmatic expression and its nuclear translocation are associated with an increased TLR-2 expression. Ital J Pediatr. 2013;39:29.
21. Namazova-Baranova LS, Alekseeva AA, Kharit SM, Kozhevnikova TN, Taranushenko TE, Tuzankina IA, et al. Efficacy and safety of pidotimod in the prevention of recurrent respiratory infections in children: a multicentre study. Int J Immunopathol Pharmacol. 2014;27:413-9.
22. Licari A, De Amici M, Nigrisoli S, Marseglia A, Caimmi S, Artusio L, et al. Pidotimod may prevent recurrent respiratory infections in children. Minerva Pediatr. 2014;66:363-7.
23. Zuccotti GV, Mameli C, Trabattoni D, Beretta S, Biasin M, Guazzarotti L, et al. Immunomodulating activity of pidotimod in children with down syndrome. J Biol Regul Homeost Agents. 2013;27:253-8.
24. Tan TQ, Mason EO Jr, Wald ER, Barson WJ, Schutze GE, Bradley JS, et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 2002;110:1-6.
25. Principi N, Esposito S. Management of severe community-acquired pneumonia of children in developing and developed countries. Thorax. 2011;66:815-22.
26. World Health Organization, Pneumonia Vaccine Trial Investigators' Group. Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children. WHO/V&B/01.35. Geneva: World Health Organization; 2001.
27. Esposito S, Indinnimeo L, Duse M, Giancane G, Battistini E, Longhi R, et al. Diagnosis and treatment of community-acquired pneumonia in pediatric age-guidelines of the Italian Pediatric Societies (SIP, SITIP, SIMRI, SIAIP, SIPPS, SIMEUP). Minerva Pediatr. 2009;61:887-90.
28. Dalod M, Chelbi R, Malissen B, Lawrence T. Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming. EMBO J. 2014;33:1104-16.
29. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol. 2013;31:563-604.
30. Kim CH, Kim DJ, Lee SJ, Jeong YJ, Kang MJ, Lee JY, et al. Toll-like receptor 2 promotes bacterial clearance during the initial stage of pulmonary infection with Acinetobacter baumannii. Mol Med Rep. 2014;9:1410-4.
31. Wiesner J, Vilcinskas A. Antimicrobial peptides: the ancient arm of the human immune system. Virulence. 2010;1:440-64.
32. Guaní-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Terán LM. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol. 2010;135:1-11.
33. Al-Rayahi IA, Sanyi RH. The overlapping roles of antimicrobial peptides and complement in recruitment and activation of tumor-associated inflammatory cells. Front Immunol. 2015;6:2.